195 related articles for article (PubMed ID: 10980887)
1. Dual-chamber pacing in hypertrophic cardiomyopathy.
Gilligan DM
Curr Cardiol Rep; 2000 Mar; 2(2):154-9. PubMed ID: 10980887
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
[TBL] [Abstract][Full Text] [Related]
3. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
Fananapazir L; Cannon RO; Tripodi D; Panza JA
Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522
[TBL] [Abstract][Full Text] [Related]
4. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).
Maron BJ; Nishimura RA; McKenna WJ; Rakowski H; Josephson ME; Kieval RS
Circulation; 1999 Jun; 99(22):2927-33. PubMed ID: 10359738
[TBL] [Abstract][Full Text] [Related]
5. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
Nishimura RA; Trusty JM; Hayes DL; Ilstrup DM; Larson DR; Hayes SN; Allison TG; Tajik AJ
J Am Coll Cardiol; 1997 Feb; 29(2):435-41. PubMed ID: 9015001
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest.
Gadler F; Linde C; Juhlin-Dannfelt A; Ribeiro A; Rydén L
Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895
[TBL] [Abstract][Full Text] [Related]
7. Pacing in obstructive hypertrophic cardiomyopathy: a therapeutic option?
Kukar A; Sherrid MV; Ehlert FA
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():49-54. PubMed ID: 17162271
[TBL] [Abstract][Full Text] [Related]
8. Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000.
Erwin JP; Nishimura RA; Lloyd MA; Tajik AJ
Mayo Clin Proc; 2000 Feb; 75(2):173-80. PubMed ID: 10683657
[TBL] [Abstract][Full Text] [Related]
9. Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study.
Galve E; Sambola A; Saldaña G; Quispe I; Nieto E; Diaz A; Evangelista A; Candell-Riera J
Heart; 2010 Mar; 96(5):352-6. PubMed ID: 19482844
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy.
Minami Y; Kajimoto K; Kawana M; Hagiwara N; Sherrid MV
Int J Cardiol; 2010 May; 141(2):195-7. PubMed ID: 19097655
[TBL] [Abstract][Full Text] [Related]
11. Hypertensive left ventricular hypertrophy with left ventricular outflow tract obstructive physiology: a case of successful treatment with dual-chamber pacing.
Wicks AB; Stajduhar K; Mascette A
Mil Med; 1998 Dec; 163(12):861-3. PubMed ID: 9866370
[TBL] [Abstract][Full Text] [Related]
12. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study.
Nishimura RA; Hayes DL; Ilstrup DM; Holmes DR; Tajik AJ
J Am Coll Cardiol; 1996 Feb; 27(2):421-30. PubMed ID: 8557915
[TBL] [Abstract][Full Text] [Related]
13. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
[TBL] [Abstract][Full Text] [Related]
14. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
[TBL] [Abstract][Full Text] [Related]
15. Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.
Qintar M; Morad A; Alhawasli H; Shorbaji K; Firwana B; Essali A; Kadro W
Cochrane Database Syst Rev; 2012 May; 2012(5):CD008523. PubMed ID: 22592731
[TBL] [Abstract][Full Text] [Related]
16. Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.
Haruki S; Minami Y; Kajimoto K; Yashiro B; Suzuki T; Kawana M; Hagiwara N
Eur J Heart Fail; 2010 Jan; 12(1):94-7. PubMed ID: 19942605
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points.
Ommen SR; Nishimura RA; Squires RW; Schaff HV; Danielson GK; Tajik AJ
J Am Coll Cardiol; 1999 Jul; 34(1):191-6. PubMed ID: 10400010
[TBL] [Abstract][Full Text] [Related]
18. [Pacemaker therapy of hypertrophic obstructive cardiomyopathy. PIC (Pacing in Cardiomyopathy) Study Group].
Meisel E; Rauwolf T; Burghardt M; Kappenberger L
Herz; 2000 Jun; 25(4):461-6. PubMed ID: 10948782
[TBL] [Abstract][Full Text] [Related]
19. Dual chamber pacing in hypertrophic cardiomyopathy: long-term effects on diastolic function.
Betocchi S; Elliott PM; Briguori C; Virdee M; Losi MA; Matsumura Y; Miranda M; McKenna WJ; Chiariello M
Pacing Clin Electrophysiol; 2002 Oct; 25(10):1433-40. PubMed ID: 12418740
[TBL] [Abstract][Full Text] [Related]
20. Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy.
Rishi F; Hulse JE; Auld DO; McRae G; Kaltman J; Kanter K; Williams W; Campbell RM
J Am Coll Cardiol; 1997 Mar; 29(4):734-40. PubMed ID: 9091517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
